Guyon Espiner
Pharmac knew about deaths linked to drug brand switch
What were they waiting for? That's the question a grieving mother has for Pharmac - after her 27-year-old son died while switching to a generic version of his epilepsy medication called Logem. It's… Audio
Coroner to investigate deaths linked to Logem
More pressure is being heaped on Pharmac over its brand switch of epilepsy drugs.
The Chief Coroner has announced she is launching an investigation into four deaths linked to Logem - a brand of… Video, Audio
Document leak: Why the NZ First Foundation was set up
Key documents about a mysterious foundation loaning money to New Zealand First have been leaked to RNZ detailing why the New Zealand First Foundation was set up, how it would operate and who knew… Video, Audio
Pharmac breached patient rights during drug brand switch
A woman who's made a complaint against Pharmac to the Health and Disability Commissioner says the drug-buying agency breached patient rights. Four people died following an epilepsy drug brand switch… Audio
Guyon Espiner reflects on Māori attitudes in his childhood
RNZ's In Depth team launched a new project a few weeks ago called Now We are Five (Million). Guyon Espiner has been looking at Māori culture in the country and how attitudes have changed. Audio
Pharmac's retreat on cheaper anti-epilepsy drug change - explained
Pharmac has been left red-faced as a cost-saving initiative appears to have backfired, and it retreated on its plan to shift thousands of patients from their prescribed drugs to a cheaper alternative.
…Powerful New Zealand First figure helped set up a forestry company that wanted govt funds
A powerful New Zealand First figure helped establish a forestry company that then pushed for money from two key funding streams controlled by a New Zealand First Minister.
An RNZ investigation has… Audio
Three deaths reported after epilepsy drug switch
Three deaths have been reported to the Centre for Adverse Reactions Monitoring after Pharmac forced patients using the medicine Lamotrigine to switch brands.
About 11,000 people - most with epilepsy… Video, Audio
Mother urges vigilance over anti-epileptic medicine
A woman who fears her daughter's death is linked to a change in her epilepsy medicine is urging vigilance among the 11,000 people being forced to switch drug brands by a Pharmac cost-saving drive. In… Audio
Austrian Countess fined over NZ land purchase
An Austrian Countess who breached New Zealand's overseas investment rules when she bought Hadleigh Station in Wairarapa has been fined just a fraction of the purchase price and been allowed to keep… Audio
Uber eats or judges as cuckoo clocks? Three experts discuss how to make access to the civil justice system cheaper and fairer
Guyon Espiner talks at Parliament with Dr Bridgette Toy-Cronin, Justice Forrest Miller and Leo Watson. Recorded in July 2019 in association with the University of Otago. Audio
Sir John Key may be forced to stand down from banking role
Former Prime Minister Sir John Key could be forced to stand down from one of his banking roles rather than chair both the ANZ in New Zealand and sit on the board of its parent bank in Australia… Audio
Adrian Orr: The Reserve Bank governor taking on the Aussie banks
The Reserve Bank's Governor thinks the big 4 Australian banks are making too much money in NZ. Guyon Espiner investigates efforts to rein them in. Audio
Epilepsy meds switch-up affects thousands
People with epilepsy say their lives are being turned upside down by seizures after the government drug buying agency, Pharmac, pulled funding for their medicines in a cost savings drive. Multiple… Audio
Saving our coasts from climate change means not building pointless and expensive seawalls
Guyon Espiner talks with a panel of University of Otago experts: Associate Professor Janet Stephenson, Dr Ben France-Hudson. Dr Caroline Orchiston and Professor Lisa Ellis. Audio
Tobacco giant targets poor people to promote vaping products
Tobacco giant Philip Morris has been trying to gain access to a major Auckland poverty group in a bid to promote its vaping and smokeless tobacco devices to poor people. The tobacco company has also… Audio
Anti-smoking campaigner defends funding from tobacco giant
A finalist for New Zealander of the Year for her work with Maori smokers is facing being shut out of the public health system because her research is funded by tobacco giant Philip Morris. Yesterday… Audio
What does Boris Johnson leadership mean for NZ?
Former UK Foreign Secretary Boris Johnson will be the next Prime Minister of the United Kingdom.
Two years ago Boris Johnson was in New Zealand and he spoke to Morning Report about post Brexit… Audio
Jenny Salesa ‘skeptical’ about Big Tobacco’s claims
Associate Health Minister Jenny Salesa says tactics deployed by tobacco giant Philip Morris in targeting Māori to use its new e-cigarette are motivated by money and not concern for public health. She… Audio
NZ should be worried about Juul vaping device – US professor
Dr Alex Carll, an assistant professor of physiology at the University of Louisville, says the high nicotine levels in JUUL may present cardiovascular risks - and New Zealand should be concerned about… Audio